April 2, 2026 - At the Alliance for Clinical Trials in Oncology, we love sharing stories that show what’s happening in cancer research right now. Whether it’s a new clinical trial, a scientific breakthrough, or the work of one of our dedicated investigators, we want people to see the progress being made, and the real humans behind it.
These stories help explain why clinical trials matter so much in
March 25, 2026
Published results show adjuvant atezolizumab plus mFOLFOX6 significantly reduces recurrence risk and delivers the first proven immunotherapy benefit in early stage dMMR disease.
A new study from researchers at the Alliance for Clinical Trials in Oncology (Alliance) shows that patients with stage III colon cancer with deficient deoxyribonucleic acid (DNA) mis
March 23, 2026
During Multiple Myeloma Awareness Month, the Alliance for Clinical Trials in Oncology and the Alliance Foundation Trials (AFT) are spotlighting several innovative research studies designed to improve treatment and long-term outcomes for people diagnosed with this rare blood cancer.
Multiple myeloma is a blood cancer that forms in plasma cells, an important part of the
